You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Allergies and anaphylaxis

Dupilumab for treating eosinophilic oesophagitis in people 12 years and over (terminated appraisal)

  • Technology appraisal
  • Reference number: TA938
  • Published:  07 December 2023
  • Guidance
  • Tools and resources
  • History

26747-Dupilumab-for-Eosinophilic-Esophagitis-V1.0-MAR2022-NONCONF_OS.pdf (nihr.ac.uk)

This page was last updated: 21 April 2022

Back to top